CardioPump device shows promise in cardiac arrest survival
University of Minnesota researchers studied 81 cardiac arrest patients treated within 10 minutes, 49 CPR plus CardioPump and 32 standard CPR. Fifty-nine percent of pump patients reached the hospital alive versus 33 percent with standard CPR, and 38 percent were discharged. FDA halted two year study after 10 months citing consent and risk concerns.
MENTIONED IN THIS ARTICLE
Keith Lurie
University of Minnesota
Journal of the American Medical Association
University of California-San Francisco
St. Paul, Minn
St. Paul-Ramsey Medical Center
Hospital. Com
New asthma drug Serevent shows enhanced effectiveness
Researchers report in a Wednesday issue of The Journal of the American Medical Association that a new asthma medication demonstrates greater effectiveness. The drug is intended for U S marketing under the brand name Serevent.
MENTIONED IN THIS ARTICLE
Journal of the American Medical Association
United States
Serevent
The
Journal of the American Medical
Also Mentioned on This Page
FDA
Escuela
Lurie
McLearn
Associated Press
Rochelle Malinoff
Hearing & Speech
Cigna HealthCare
Mesa-Stapley
Cigna HealthCare of
Arizona
E. Superstition Springs Blvd
Tempe
Thur
Sun
Youngtown
Chandler
Ture
Bun
St “Ory